Beta thalassemia Clinical Trials

• Combined Chelation Treatment with Deferiprone and Deferoxamine in Thalassemia Major
  ClinicalTrials.gov Identifier: NCT00103753 - Active, not recruiting
  beta-Thalassemia
  
• Genetic Factors Affecting the Severity of Beta Thalassemia
  ClinicalTrials.gov Identifier: NCT00159042 - Recruiting
  beta Thalassemia
  
• Extension Study on Efficacy and Safety of Deferasirox Treatment in Patients With Beta-Thalassemia and Transfusional Hemosiderosis
  ClinicalTrials.gov Identifier: NCT00171301 - Active, not recruiting
  Beta-Thalassemia Major
  
• Thalassemia Clinical Research Network - Cardiac L1/DFO Trial
  ClinicalTrials.gov Identifier: NCT00115349 - Recruiting
  Cardiovascular Diseases; Heart Diseases; Thalassemia; Anemia (Cooley''s); beta-Thalassemia
  
• Cardiac T2* in Beta-Thalassemia Patients on Deferasirox Treatment
  ClinicalTrials.gov Identifier: NCT00447694 - Recruiting
  Beta-Thalassemia; Iron Overload
  
• Evaluating the Safety of G-CSF Mobilization in Individuals With Beta Thalassemia Major
  ClinicalTrials.gov Identifier: NCT00336362 - Recruiting
  Beta-Thalassemia
  
• Safety & Efficacy of ICL670 vs. deferoxamine in Beta-thalassemia patients with iron overload due to blood transfusions
  ClinicalTrials.gov Identifier: NCT00061750 - Completed
  beta-Thalassemia
  
• Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)
  ClinicalTrials.gov Identifier: NCT00001958 - Completed
  Beta Thalassemia; Hemoglobinopathy
  
• 5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia
  ClinicalTrials.gov Identifier: NCT00005934 - Completed
  Beta Thalassemia
  
• Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)
  ClinicalTrials.gov Identifier: NCT00000623 - Completed
  Anemia (Cooley's); beta-Thalassemia; Blood Disease; Thalassemia; Osteoporosis
  
• Iron Balance Study of DFO and GT56-252 in Patients with Transfusional Iron Overload Secondary to Beta-Thalassemia
  ClinicalTrials.gov Identifier: NCT00069862 - Completed
  beta-Thalassemia
  
• A Study of Long-Term Treatment With Deferasirox in Patients With Beta-Thalassemia and Transfusional Hemosiderosis
  ClinicalTrials.gov Identifier: NCT00171171 - Completed
  Beta-Thalassemia; Hemosiderosis
  
• Study of ICL670 in iron overload from beta-thalassemia unable to be treated with deferoxamine or chronic anemias
  ClinicalTrials.gov Identifier: NCT00061763 - Completed
  beta-Thalassemia; Myelodysplastic Syndromes; Fanconi Syndrome; Anemia, Diamond-Blackfan; Anemia, Aplastic
  
• Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis
  ClinicalTrials.gov Identifier: NCT00000595 - Completed
  Anemia (Iron-Loading); beta-Thalassemia; Hematologic Diseases; Hemoglobinopathies; Thalassemia; Iron Overload; Hemochromatosis
  
• Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-Thalassaemia Patients) With Chronic Iron Overload
  ClinicalTrials.gov Identifier: NCT00564941 - Not yet recruiting
  Myelodysplastic Syndromes; Beta-Thalassemia
  
• Phase II Study of Arginine Butyrate With or Without Epoetin alfa in Patients With Thalassemia Intermedia
  ClinicalTrials.gov Identifier: NCT00006136 - Completed
  beta-Thalassemia
  
• Stem Cell Transplant in Sickle Cell Disease and Thalassemia
  ClinicalTrials.gov Identifier: NCT00408447 - Recruiting
  Sickle Cell Disease; Beta Thalassemia
  
• Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone
  ClinicalTrials.gov Identifier: NCT00000588 - Completed
  Anemia (Iron-Loading); beta-Thalassemia; Hematologic Diseases; Hemoglobinopathies; Thalassemia; Iron Overload
  
• Stem Cell Transplantation after Reduced-Dose Chemotherapy for Patients with Sickle Cell Disease or Thalassemia
  ClinicalTrials.gov Identifier: NCT00034528 - Active, not recruiting
  Hemoglobinopathies; Anemia, Sickle Cell; Hemoglobin SC Disease; Thalassemia; Thalassemia Major
  
• Evaluating the Safety of Two Medications to Treat Hepatitis C in People With Thalassemia (The HepC Study)
  ClinicalTrials.gov Identifier: NCT00502788 - Active, not recruiting
  Hepatitis C; Thalassemia
  
• Genetics of Alpha Thalassemia in Israeli Ethnic Groups
  ClinicalTrials.gov Identifier: NCT00159029 - Recruiting
  alpha Thalassemia
  
• Detection of β Thalassemia Carriers by Red Cell Parameters Obtained From the H2 Automatic Counter
  ClinicalTrials.gov Identifier: NCT00481221 - Recruiting
  Thalassemia; Iron Deficiency
  
• Stem Cell Transplant in Patients With Thalassemia
  ClinicalTrials.gov Identifier: NCT00578292 - Recruiting
  Thalassemia
  
• Factors Promoting Increased Rate and Success of Pregnancy in the Thalassemia Population in Toronto
  ClinicalTrials.gov Identifier: NCT00327639 - Recruiting
  Thalassemia; Fertility; Pregnancy
  
• Zinc to Improve Bone Health in People With Thalassemia (The Think Zinc Study)
  ClinicalTrials.gov Identifier: NCT00480415 - Recruiting
  Thalassemia
  
• Zinc & Bone Health in Thalassemia: The Think Zinc Study
  ClinicalTrials.gov Identifier: NCT00459732 - Recruiting
  Thalassemia
  
• Endocrine and Nutritional Assessment in B Thalassemia Major
  ClinicalTrials.gov Identifier: NCT00456690 - Not yet recruiting
  Thalassemia
  
• An Extension Study of Iron Chelation Therapy With Deferasirox in β-Thalassemia Patients With Transfusional Iron Overload
  ClinicalTrials.gov Identifier: NCT00171210 - Active, not recruiting
  Transfusional Iron Overload in β-Thalassemia
  
• Iron Chelation Therapy With Deferasirox in β-Thalassemia Major Pediatric Patients With Transfusional Iron Overload
  ClinicalTrials.gov Identifier: NCT00390858 - Active, not recruiting
  Transfusional Iron Overload in β-Thalassemia Major
  
• Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-Thalassemia Patients With Transfusional Iron Overload
  ClinicalTrials.gov Identifier: NCT00560820 - Recruiting
  β-Thalassemia; Transfusional Iron Overload
  
• L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia
  ClinicalTrials.gov Identifier: NCT00125788 - Active, not recruiting
  Sickle Cell Anemia (homozygous); Sickle ß0-Thalassemia
  
• Is IFN-Beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta
  ClinicalTrials.gov Identifier: NCT00493116 - Active, not recruiting
  Relapsing-Remitting Multiple Sclerosis
  
• Deferoxamine for the Treatment of Hemochromatosis
  ClinicalTrials.gov Identifier: NCT00001203 - Active, not recruiting
  Diabetes Mellitus; Heart Disease; Hemochromatosis; Thalassemia
  
• Study of Protein Translocation in Patients With Beta-Oxidation Disorders
  ClinicalTrials.gov Identifier: NCT00004348 - Active, not recruiting
  Beta-Oxidation Disorder; Peroxisomal Disorders
  
• Beta-Blocker Continuation Versus Interruption in Heart Failure Worsening
  ClinicalTrials.gov Identifier: NCT00162565 - Recruiting
  Heart Failure,Congestive; beta-Adrenergic Blockers
  
• Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients with Hemoglobinopathies
  ClinicalTrials.gov Identifier: NCT00153985 - Recruiting
  Hemoglobinopathies; Sickle Cell Disease; Thalassemia
  
• Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study)
  ClinicalTrials.gov Identifier: NCT00562172 - Recruiting
  Type 2 Diabetes Mellitus
  
• Safety and antiviral study of ACH-126, 443 (beta-L-Fd4C) in the treatment of adults with HIV infection and modestly detectable viral load.
  ClinicalTrials.gov Identifier: NCT00040157 - Active, not recruiting
  HIV Infections
  
• Evaluation of Efficacy of Zoledronic Acid in Patients With Haemoglobin Syndromes (Thalassemia and Sicle Cell Anaemia) and Risk of Skeletal Events
  ClinicalTrials.gov Identifier: NCT00346242 - Completed
  Thalassemia
  
• Beta Alethine in Treating Patients With Low-Grade Lymphoma
  ClinicalTrials.gov Identifier: NCT00007839 - Active, not recruiting
  Lymphoma
  
• Safety Study of Interferon Beta 1a to for Acute Stroke
  ClinicalTrials.gov Identifier: NCT00097318 - Active, not recruiting
  Cerebrovascular Accident
  
• Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy
  ClinicalTrials.gov Identifier: NCT00474838 - Recruiting
  Type 2 Diabetes Mellitus; Pancreatic Beta Cell Function; Glucotoxicity
  
• Diagnostic Pilot Study of Dual Energy Absorptiometry in the Detection of Osteopenia or Osteoporosis in Patients With Thalassemia Major
  ClinicalTrials.gov Identifier: NCT00006138 - Completed
  Osteoporosis; Thalassemia Major; Osteopenia
  
• Beta Blockers Versus Variceal Band Ligation and Beta Blockers for Primary Prophylaxis of Variceal Bleeding
  ClinicalTrials.gov Identifier: NCT00409084 - Recruiting
  Esophageal Varices
  
• Randomized Trial of Beta-Carotene and Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00000152 - Active, not recruiting
  Macular Degeneration
  
• L-glutamine Therapy for Sickle Cell Anemia
  ClinicalTrials.gov Identifier: NCT00029887 - Recruiting
  Anemia, Sickle Cell; Thalassemia
  
• Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00041379 - Active, not recruiting
  Waldenstrom's Macroglobulinemia
  
• Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major
  ClinicalTrials.gov Identifier: NCT00480506 - Completed
  Thalassemia Major
  
• Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload
  ClinicalTrials.gov Identifier: NCT00235391 - Active, not recruiting
  Thalassemia; Sickle Cell Disease; Diamond Blackfan Anemia; Myelofibrosis
  
• Phase I/II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation in Patients With High Risk Hemoglobinopathy
  ClinicalTrials.gov Identifier: NCT00005897 - Recruiting
  Graft Versus Host Disease; Sickle Cell Anemia; Thalassemia
  
• Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell Thalassemia
  ClinicalTrials.gov Identifier: NCT00512564 - Not yet recruiting
  Sickle Cell Anemia; Sickle Cell Thalassemia
  
• Safety and antiviral study of ACH-126, 443 (beta-L-Fd4C) in the treatment of adults with chronic Hepatitis B infection.
  ClinicalTrials.gov Identifier: NCT00037622 - Active, not recruiting
  Chronic Hepatitis B
  
• Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase
  ClinicalTrials.gov Identifier: NCT00414193 - Recruiting
  Bacteremia; AmpC Beta-Lactamase
  
• Efficacy Study in Removing Excess Iron from the Heart
  ClinicalTrials.gov Identifier: NCT00105495 - Completed
  Thalassemia Major; Hemosiderosis
  
• Hu-Mik-(Beta)1 to Treat T-Cell Large Granular Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00076180 - Recruiting
  Leukemia, T-Cell
  
• beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00037011 - Active, not recruiting
  disseminated neuroblastoma; recurrent neuroblastoma
  
• Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients
  ClinicalTrials.gov Identifier: NCT00151801 - Recruiting
  Multiple Sclerosis
  
• A Pilot Study of HSCT for Patients With High-Risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen
  ClinicalTrials.gov Identifier: NCT00427661 - Recruiting
  Sickle Cell Disease; Thalassemia; Hemoglobinopathies
  
• Stem Cell Transplant for Hemoglobinopathy
  ClinicalTrials.gov Identifier: NCT00176852 - Recruiting
  Sickle Cell Disease; Thalassemia
  
• Long-Acting Beta Agonist Response by Genotype
  ClinicalTrials.gov Identifier: NCT00200967 - Active, not recruiting
  Asthma
  
• Effects of (1,3), (1,6)-Beta-D-Glucan on Insulin Sensitivity and Inflammatory Markers of the Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00403689 - Active, not recruiting
  Overweight
  
• A Study of NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease.
  ClinicalTrials.gov Identifier: NCT00413101 - Active, not recruiting
  Anemia
  
• Elder Surgery - Functional Recovery Following Beta Blockade
  ClinicalTrials.gov Identifier: NCT00507663 - Active, not recruiting
  Post Operative Cognitive Dysfunction
  
• Beta-Carotene and Alpha-Tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients
  ClinicalTrials.gov Identifier: NCT00169845 - Active, not recruiting
  Neoplasms
  
• Investigating if Interferon-Beta Can be Used in Patients With MS After They Have Developed Neutralizing Antibodies
  ClinicalTrials.gov Identifier: NCT00492466 - Active, not recruiting
  Relapsing-Remitting Multiple Sclerosis
  
• Interferon-beta Treatment of Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00048347 - Recruiting
  Ulcerative Colitis
  
• Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell Thalassemia
  ClinicalTrials.gov Identifier: NCT00512226 - Not yet recruiting
  Sickle Cell Anemia; Sickle Cell Thalassemia; Iron Overload; MRI
  
• Beta Alethine in Treating Patients With Myeloma
  ClinicalTrials.gov Identifier: NCT00006466 - Active, not recruiting
  monoclonal gammopathy of undetermined significance; stage I multiple myeloma; stage II multiple myeloma; extramedullary plasmacytoma; ...
  
• Surveillance of Streptococcal Infections in Children in India
  ClinicalTrials.gov Identifier: NCT00342199 - Active, not recruiting
  Group A Beta Hemolytic Streptococcal (GAS) Infection
  
• Extension Study of Iron Chelation Therapy With Deferasirox in β-Thalassemia and Other Patients With Rare Chronic Anemia and Transfusional Iron Overload
  ClinicalTrials.gov Identifier: NCT00303329 - Active, not recruiting
  Transfusional Iron Overload in Patients With Chronic Anemia
  
• The Effect of Beta-Blockers and Aspirin on Hemostasis and Endothelial Function After Acute Mental Stress
  ClinicalTrials.gov Identifier: NCT00174902 - Active, not recruiting
  Arteriosclerosis; Stress, Psychological
  
• Treatment of Menstrual Migraine With Sequential, Transdermal, 17-Beta-Estradiol. A Double-Blind, Randomised, Cross-Over Trial.
  ClinicalTrials.gov Identifier: NCT00204074 - Active, not recruiting
  Migraine
  
• Pilot Study on Safety and Efficacy of MD05 in Comparison With Beta-TCP in Patients Undergoing Sinus Floor Augmentation
  ClinicalTrials.gov Identifier: NCT00520377 - Active, not recruiting
  Alveolar Ridge Augmentation
  
• Luteal Phase FSH in the IVF Poor Reponder
  ClinicalTrials.gov Identifier: NCT00225433 - Active, not recruiting
  Infertility
  
• A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections
  ClinicalTrials.gov Identifier: NCT00303589 - Active, not recruiting
  Soft Tissue Infections
  
• Treatment of Congenital Stationary Night Blindness With an Alga Containing High Dose of Beta Carotene
  ClinicalTrials.gov Identifier: NCT00569023 - Enrolling by invitation
  Night Blindness
  
• Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
  ClinicalTrials.gov Identifier: NCT00342992 - Active, not recruiting
  Lung Cancer; Prostatic Neoplasms; Prostate Cancer; Pancreatic Cancer
  
• A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.
  ClinicalTrials.gov Identifier: NCT00551291 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Beta Blockade in Critical Injury
  ClinicalTrials.gov Identifier: NCT00356187 - Recruiting
  Trauma
  
• Beta-Blocker Before Extubation
  ClinicalTrials.gov Identifier: NCT00563238 - Recruiting
  Myocardial Ischemia
  
• Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00087009 - Recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma
  
• Beta-2 Polymorphisms and Beta Receptor Selectivity
  ClinicalTrials.gov Identifier: NCT00214318 - Completed
  Heart Failure
  
• Beta Blocker for Chronic Wound Healing
  ClinicalTrials.gov Identifier: NCT00368602 - Recruiting
  Ulcer; Burns
  
• Beta Cell Function in Women With Turner Syndrome
  ClinicalTrials.gov Identifier: NCT00419107 - Active, not recruiting
  Turner Syndrome
  
• Beta-Cell Function and Sitagliptin Trial (BEST)
  ClinicalTrials.gov Identifier: NCT00420511 - Recruiting
  Type 2 Diabetes Mellitus
  
• Evaluation of [123I] MNI-308 and SPECT as a Marker of Beta-Amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00544453 - Active, not recruiting
  Alzheimer Disease
  
• Avonex (Interferon-Beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-Remitting MS
  ClinicalTrials.gov Identifier: NCT00168766 - Active, not recruiting
  Relapsing-Remitting Multiple Sclerosis
  
• Gene Expression in MS Patients Before and During Treatment With Interferon-Beta
  ClinicalTrials.gov Identifier: NCT00202384 - Recruiting
  Multiple Sclerosis
  
• BOAT: Beta Blocker Uptitration With OptiVol After CRT.
  ClinicalTrials.gov Identifier: NCT00433043 - Recruiting
  Congestive Heart Failure
  
• Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid
  ClinicalTrials.gov Identifier: NCT00437450 - Active, not recruiting
  Anemia in Myelodysplastic Syndromes
  
• Physicians' Health Study II: Vitamin E, Ascorbic Acid, Beta Carotene, and/or Multivitamins in Preventing Cancer and Cardiovascular Disease in Older Healthy Male Doctors
  ClinicalTrials.gov Identifier: NCT00270647 - Active, not recruiting
  Colorectal Cancer; Prostate Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• BEYOND Study - Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
  ClinicalTrials.gov Identifier: NCT00099502 - Active, not recruiting
  Multiple Sclerosis
  
• Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy
  ClinicalTrials.gov Identifier: NCT00574405 - Recruiting
  Diabetes Mellitus
  
• Collaborative Initial Glaucoma Treatment Study (CIGTS)
  ClinicalTrials.gov Identifier: NCT00000149 - Active, not recruiting
  Open-Angle Glaucoma
  
• Effect of AC2993 with or without Immunosuppression on Beta Cell Function in Patients with Type I Diabetes
  ClinicalTrials.gov Identifier: NCT00064714 - Active, not recruiting
  Diabetes Mellitus
  
• Rebif® New Formulation in Relapsing Forms of Multiple Sclerosis (RMS)
  ClinicalTrials.gov Identifier: NCT00110396 - Active, not recruiting
  Multiple Sclerosis
  
• Combination Therapy with Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00037102 - Active, not recruiting
  Multiple Sclerosis
  
• Minocycline as Add-on to Interferon-Beta-1a (Rebif®) in RRMS (Recycline)
  ClinicalTrials.gov Identifier: NCT00381459 - Recruiting
  Relapsing-Remitting Multiple Sclerosis
  
• Epidemiology of Community - Associated Extended-Spectrum Beta-Lactamases (ESBL) Producing Escherichia Coli
  ClinicalTrials.gov Identifier: NCT00573235 - Recruiting
  Enterobacteriaceae Infections
  
• Preservation of Beta-Cell Function in Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00232583 - Active, not recruiting
  Type 2 Diabetes Mellitus